Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathwaysSandra E. Ghayad, Pascale A. Cohen, Julie A. Vendrell et al.|International Journal of Cancer|2009Cited by 131
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cellsAurélie Thollet, Pascale A. Cohen, Marie Villedieu et al.|Molecular Cancer|2010Cited by 51
Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of <i>de novo</i> or acquired resistance and importance of combining the allosteric Akt inhibitor MK‐2206 with an aromatase inhibitorPaul Vilquin, Pascale A. Cohen, Marie Villedieu et al.|International Journal of Cancer|2013Cited by 47
989 Acquired Resistance to Aromatase Inhibitors is Paired With Hyper-activation of Akt/mTor Pathway in New Cellular Models of Hormone-dependent Breast CancerPaul Vilquin, Pascale A. Cohen, Marie Villedieu et al.|European Journal of Cancer|2012Cited by 0
113: ZNF-X conferred increased cell proliferation and resistance to the pro-apoptotic action of paclitaxel in breast cancer cellsAurélie Thollet, Pascale A. Cohen, Julie A. Vendrell et al.|Bulletin du Cancer|2010Cited by 0